Genetic variant of AKT1 and AKTIP associated with late-onset depression in a Brazilian population

International Journal of Geriatric Psychiatry

Volumn 29, Issue 4, 2014, Pages 399-405

  Pereira, Patricia Araújo ^a   Bicalho, Maria Aparecida Camargos ^a   De Moraes, Edgar Nunes ^a   Malloy Diniz, Leandro ^a   Bozzi, Isadora Cristine Reis Sguizzato ^a   Nicolato, Rodrigo ^a   Valadão, Daniela Rosa ^a   Miranda, Debora Marques ^a   Romano Silva, Marco Aurélio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

AKT Interaction Protein (AKTIP); late onset depression (LOD); serotonin (5 HT); single nucleotide polymorphism (SNP); V akt murine thymoma viral oncogene homolog 1 (AKT1)

Indexed keywords

AGED; AKT INTERACTION PROTEIN GENE; ARTICLE; BRAZIL; DEPRESSION; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LATE ONSET DEPRESSION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; SINGLE NUCLEOTIDE POLYMORPHISM; V AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1 GENE;

AKT INTERACTION PROTEIN (AKTIP); LATE-ONSET DEPRESSION (LOD); SEROTONIN (5-HT); SINGLE-NUCLEOTIDE POLYMORPHISM (SNP); V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1 (AKT1);

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; APOPTOSIS REGULATORY PROTEINS; BRAZIL; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE FREQUENCY; GENETIC VARIATION; HUMANS; MALE; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84895806623     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4018     Document Type: Article

References (40)

1. Alexopoulos GS, Schultz SK, Lebowitz BD,. 2005. Late-life depression: a model for medical classification. Biol Psychiatry 58: 283-289.
2. Almeida OP, Almeida SA,. 1999. Reliability of the Brazilian version of the ++abbreviated form of Geriatric Depression Scale (GDS) short form. Arq Neuropsiquiatr 57 (2B): 421-426.
3. Amorim P, 2000. Mini International Neuropsychiatric Interview (MINI): validation of a short structured diagnostic psychiatric interview. Rev Bras Psiquiatr 22: 106-115.
4. Andersen I, Thielen K, Bech P, Nygaard E, Diderichsen F,. 2011. Increasing prevalence of depression from 2000 to 2006. Scand J Public Health 39: 857-863.
5. Barnes DE, Yaffe K, Byers AL, et al,. 2012. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry 69: 493-498.
6. Beaulieu JM, Gainetdinov RR, Caron MG,. 2009. Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 49: 327-347.
7. Benedetti F, Bernasconi A, Lorenzi C, et al,. 2004. A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett 355: 37-40.
8. Brommelhoff JA, Gatz M, Johansson B, et al,. 2009. Depression as a risk factor or prodromal feature for dementia? Findings in a population-based sample of Swedish twins. Psychol Aging 24: 373-384.
9. Chen LM, Xiong YS, Kong FL, et al,. 2012. Neuroglobin attenuates Alzheimer-like tau hyperphosphorylation by activating Akt signaling. J Neurochem 120: 157-164.
10. Cheng A, Wang S, Yang D, Xiao R, Mattson MP,. 2003. Calmodulin mediates brain-derived neurotrophic factor cell survival signaling upstream of Akt kinase in embryonic neocortical neurons. J Biol Chem 278: 7591-7599.
11. Correa H, Campi-Azevedo AC, De ML, et al,. 2004. Familial suicide behaviour: association with probands suicide attempt characteristics and 5-HTTLPR polymorphism. Acta Psychiatr Scand 110: 459-464.
12. Diniz BS, Nunes PV, Hado-Vieira R, Forlenza OV,. 2011. Current pharmacological approaches and perspectives in the treatment of geriatric mood disorders. Curr Opin Psychiatry 24: 473-477.
13. Hanger DP, Noble W,. 2011. Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation. Int J Alzheimers Dis 2011, 352805.
14. Hoyer D, Hannon JP, Martin GR,. 2002. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71: 533-554.
15. Hsiung SC, Adlersberg M, Arango V, et al,. 2003. Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase. J Neurochem 87: 182-194.
16. Jorm AF,. 2001. History of depression as a risk factor for dementia: an updated review. Aust NZ J Psychiatry 35: 776-781.
17. Judd LL, Akiskal HS, Paulus MP,. 1997. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect Disord 45: 5-17.
18. Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H,. 2004. Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol Psychiatry 55: 781-784.
19. Kapur S,., Remington G,. 2001. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annu Rev Med 52: 503-517.
20. Karege F, Perroud N, Burkhardt S, et al,. 2007. Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biol Psychiatry 61: 240-245.
21. Lahiri DK, Nurnberger JI, Jr., 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19: 5444.
22. Lawlor MA, Alessi DR,. 2001. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114: 2903-2910.
23. Lenardo M, Chan KM, Hornung F, et al,. 1999. Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 17: 221-253.
24. Lesch KP,. 2004. Gene-environment interaction and the genetics of depression. J Psychiatry Neurosci 29: 174-184.
25. Lesche R, Peetz A, van der HF, Ruther U,. 1997. Ft1, a novel gene related to ubiquitin-conjugating enzymes, is deleted in the Fused toes mouse mutation. Mamm Genome 8: 879-883.
26. Liu Y, Fanburg BL,. 2006. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine- threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1. Am J Respir Cell Mol Biol 34: 182-191.
27. Magno LA, Miranda DM, Neves FS, et al,. 2010. Association between AKT1 but not AKTIP genetic variants and increased risk for suicidal behavior in bipolar patients. Genes Brain Behav 9: 411-418.
28. Martin D, Salinas M, Lopez-Valdaliso, R, et al,. 2001. Effect of the Alzheimer amyloid fragment Abeta (25-35) on Akt/PKB kinase and survival of PC12 cells. J Neurochem 78: 1000-1008.
29. O'Brien WT, Harper AD, Jove F, et al,. 2004. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci 24: 6791-6798.
30. Paradela EM, Lourenço RA, Veras RP,. 2005. Validation of geriatric depression scale in a general outpatient clinic. Rev Saude Publica 39 (6): 918-923.
31. Pei JJ, Braak E, Braak H, et al,. 1999. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 58: 1010-1019.
32. Remy I,., Michnick SW,. 2004. Regulation of apoptosis by the Ft1 protein, a new modulator of protein kinase B/Akt Mol Cell Biol 24: 1493-1504.
33. Schweitzer I, Tuckwell V, O'Brien J, Ames D,. 2002. Is late onset depression a prodrome to dementia?. Int J. Geriatr. Psychiatry 17 997-1005.
34. Serretti A, Benedetti F, Mandelli L, et al,. 2008. Association between GSK-3beta -50T/C polymorphism and personality and psychotic symptoms in mood disorders. Psychiatry Res 158: 132-140.
35. Sheikh JI, Yesavage JA,. 1985. A knowledge assessment test for geriatric psychiatry. Hosp Community Psychiatry 36 (11): 1160-1166.
36. Stein TD, Johnson JA,. 2002. Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J Neurosci 22, 7380-7388.
37. Waraich P, Goldner EM, Somers JM, Hsu L,. 2004. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry 49: 124-138.
38. Wei W, Wang X, Kusiak JW,. 2002. Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection. J Biol Chem 277: 17649-17656.
39. Yamaguchi H, Ishiguro K, Uchida T, et al,. 1996. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol 92: 232-241.
40. Zhang K, Yang C, Xu Y, et al,. 2010. Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population. J Neural Transm 117: 393-401.